The global, regional, and national burden of nasopharyngeal carcinoma and its attributable risk factors in 204 countries and territories, 1990-2019
- PMID: 36018303
- DOI: 10.1080/00016489.2022.2111711
The global, regional, and national burden of nasopharyngeal carcinoma and its attributable risk factors in 204 countries and territories, 1990-2019
Abstract
Background: Nasopharyngeal carcinoma (NPC) is uncommon in most areas of the world but poses a significant public health burden in endemic regions.
Objectives: We provide an overview of the most recent global epidemiology of nasopharyngeal cancer (NPC).
Methods: We estimated the burden of NPC in 204 countries and territories by age, sex, and Socio-Demographic Index (SDI) from 1990 to 2019.
Results: At the GBD regional level, the most severe age-standardized incidence in 2019 occurred in East Asia. From 1990 to 2019, the East Asia and High-income Asia Pacific had the greatest increase in percentage in age-standardized incidence. Central Asia and the Caribbean had the greatest increase in percentage in age-standardized disability-adjusted life-years (DALY) and death rates. At the national level, Cabo Verde, Romania, and the Cyprus reported the largest percentage increases in the age-standardized incidence. Cabo Verde, Romania, and Jamaica reported the largest increases in the age-standardized DALY and death rates.
Conclusions: The global age-standardized incidence of NPC increased globally between 1990 and 2019, especially in the East Asia.
Keywords: DALY; Global Burden of Diseases; death; incidence; nasopharyngeal carcinom; risk.
Similar articles
-
The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990-2019) and predictions to 2035.Cancer Med. 2022 Nov;11(22):4310-4320. doi: 10.1002/cam4.4783. Epub 2022 Apr 27. Cancer Med. 2022. PMID: 35475595 Free PMC article.
-
Global, regional, and national burden of ovarian cancer and the attributable risk factors in all 194 countries and territories during 2007-2017: A systematic analysis of the Global Burden of Disease Study 2017.J Obstet Gynaecol Res. 2021 Dec;47(12):4389-4402. doi: 10.1111/jog.15019. Epub 2021 Oct 20. J Obstet Gynaecol Res. 2021. PMID: 34674356
-
The global, regional, and national burden of laryngeal cancer and the attributable risk factors in all countries and territories during 2007-2017.Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1097-1105. doi: 10.52586/5012. Front Biosci (Landmark Ed). 2021. PMID: 34856756
-
Global, regional, and national epidemiology of nasopharyngeal carcinoma in middle-aged and elderly patients from 1990 to 2021.Ageing Res Rev. 2025 Feb;104:102613. doi: 10.1016/j.arr.2024.102613. Epub 2024 Dec 1. Ageing Res Rev. 2025. PMID: 39626854 Review.
-
The global burden of hemorrhagic stroke: a summary of findings from the GBD 2010 study.Glob Heart. 2014 Mar;9(1):101-6. doi: 10.1016/j.gheart.2014.01.003. Glob Heart. 2014. PMID: 25432119 Review.
Cited by
-
The adverse events of toripalimab in nasopharyngeal carcinoma based on FAERS database and bibliometric analysis.PLoS One. 2025 Jun 20;20(6):e0326216. doi: 10.1371/journal.pone.0326216. eCollection 2025. PLoS One. 2025. PMID: 40540517 Free PMC article.
-
Who determines nasopharyngeal carcinoma inpatients' medical expenditure? Importance factor ranking using the random forest model.Front Public Health. 2025 Aug 20;13:1639687. doi: 10.3389/fpubh.2025.1639687. eCollection 2025. Front Public Health. 2025. PMID: 40910063 Free PMC article.
-
High IgG titers against EBV glycoprotein 42 correlate with lower risk of nasopharyngeal carcinoma.J Clin Invest. 2025 Feb 17;135(4):e189207. doi: 10.1172/JCI189207. J Clin Invest. 2025. PMID: 39959976 Free PMC article.
-
Global and regional burden of nasopharyngeal cancer in older adults attributable to smoking and high alcohol use from 1990 to 2021.Front Public Health. 2025 Jun 12;13:1614389. doi: 10.3389/fpubh.2025.1614389. eCollection 2025. Front Public Health. 2025. PMID: 40575097 Free PMC article.
-
Non-Homologous End-Joining Pathway Genotypes Significantly Associated with Nasopharyngeal Carcinoma Susceptibility.Biomedicines. 2023 Jun 6;11(6):1648. doi: 10.3390/biomedicines11061648. Biomedicines. 2023. PMID: 37371742 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources